BULLISH (BLSH) Fundamental Analysis & Valuation

NYSE:BLSH • KYG169101204

Current stock price

36.23 USD
+0.11 (+0.3%)
At close:
35.4 USD
-0.83 (-2.29%)
Pre-Market:

This BLSH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BLSH Profitability Analysis

1.1 Basic Checks

  • BLSH had negative earnings in the past year.
  • In the past year BLSH had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BLSH reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: BLSH reported negative operating cash flow in multiple years.
BLSH Yearly Net Income VS EBIT VS OCF VS FCFBLSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • BLSH has a worse Return On Assets (-19.33%) than 89.58% of its industry peers.
  • BLSH has a worse Return On Equity (-23.78%) than 80.83% of its industry peers.
Industry RankSector Rank
ROA -19.33%
ROE -23.78%
ROIC N/A
ROA(3y)18.41%
ROA(5y)-17.64%
ROE(3y)26.96%
ROE(5y)-33.51%
ROIC(3y)N/A
ROIC(5y)N/A
BLSH Yearly ROA, ROE, ROICBLSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • The Gross Margin of BLSH (0.03%) is worse than 70.83% of its industry peers.
  • In the last couple of years the Gross Margin of BLSH has declined.
  • The Profit Margin and Operating Margin are not available for BLSH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.92%
GM growth 5YN/A
BLSH Yearly Profit, Operating, Gross MarginsBLSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BLSH Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BLSH has been increased compared to 1 year ago.
  • The number of shares outstanding for BLSH has been increased compared to 5 years ago.
  • The debt/assets ratio for BLSH has been reduced compared to a year ago.
BLSH Yearly Shares OutstandingBLSH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLSH Yearly Total Debt VS Total AssetsBLSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 66.60 indicates that BLSH is not in any danger for bankruptcy at the moment.
  • BLSH has a better Altman-Z score (66.60) than 99.17% of its industry peers.
  • BLSH has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of BLSH (0.16) is better than 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 66.6
ROIC/WACCN/A
WACCN/A
BLSH Yearly LT Debt VS Equity VS FCFBLSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • BLSH has a Current Ratio of 29.28. This indicates that BLSH is financially healthy and has no problem in meeting its short term obligations.
  • BLSH's Current ratio of 29.28 is amongst the best of the industry. BLSH outperforms 97.50% of its industry peers.
  • BLSH has a Quick Ratio of 27.69. This indicates that BLSH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 27.69, BLSH belongs to the best of the industry, outperforming 97.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 29.28
Quick Ratio 27.69
BLSH Yearly Current Assets VS Current LiabilitesBLSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BLSH Growth Analysis

3.1 Past

  • The earnings per share for BLSH have decreased strongly by -1229.62% in the last year.
  • Looking at the last year, BLSH shows a decrease in Revenue. The Revenue has decreased by -2.15% in the last year.
  • BLSH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.76% yearly.
EPS 1Y (TTM)-1229.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y49.76%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, BLSH will show a very strong growth in Earnings Per Share. The EPS will grow by 69.76% on average per year.
  • Based on estimates for the next years, BLSH will show a very strong growth in Revenue. The Revenue will grow by 24.09% on average per year.
EPS Next Y180.38%
EPS Next 2Y105.4%
EPS Next 3Y69.76%
EPS Next 5YN/A
Revenue Next Year35.88%
Revenue Next 2Y26.52%
Revenue Next 3Y24.09%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLSH Yearly Revenue VS EstimatesBLSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B 250B
BLSH Yearly EPS VS EstimatesBLSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. BLSH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BLSH. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 50.00, which means the current valuation is very expensive for BLSH.
  • 73.33% of the companies in the same industry are cheaper than BLSH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BLSH to the average of the S&P500 Index (37.39), we can say BLSH is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 50
BLSH Price Earnings VS Forward Price EarningsBLSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLSH Per share dataBLSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

  • BLSH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLSH's earnings are expected to grow with 69.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.4%
EPS Next 3Y69.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLSH Dividend Analysis

5.1 Amount

  • BLSH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLSH Fundamentals: All Metrics, Ratios and Statistics

BULLISH

NYSE:BLSH (4/10/2026, 8:08:11 PM)

Premarket: 35.4 -0.83 (-2.29%)

36.23

+0.11 (+0.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-05
Earnings (Next)N/A
Inst Owners23.31%
Inst Owner ChangeN/A
Ins Owners64.94%
Ins Owner Change0%
Market Cap5.45B
Revenue(TTM)244.81B
Net Income(TTM)-764.68M
Analysts75.56
Price Target46.41 (28.1%)
Short Float %47.95%
Short Ratio4.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.79%
Min EPS beat(2)-0.81%
Max EPS beat(2)14.38%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.26%
Min Revenue beat(2)3.18%
Max Revenue beat(2)5.34%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.44%
PT rev (3m)-13.56%
EPS NQ rev (1m)1.78%
EPS NQ rev (3m)-11.01%
EPS NY rev (1m)2.52%
EPS NY rev (3m)-7.32%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)-1.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50
P/S 0.02
P/FCF N/A
P/OCF 190.18
P/B 1.69
P/tB 1.74
EV/EBITDA N/A
EPS(TTM)-5.07
EYN/A
EPS(NY)0.72
Fwd EY2%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)0.19
OCFY0.53%
SpS1628.82
BVpS21.4
TBVpS20.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.33%
ROE -23.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.03%
FCFM N/A
ROA(3y)18.41%
ROA(5y)-17.64%
ROE(3y)26.96%
ROE(5y)-33.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.92%
GM growth 5YN/A
F-Score3
Asset Turnover61.88
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 736.37%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 29.28
Quick Ratio 27.69
Altman-Z 66.6
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)312.67%
Cap/Depr(5y)14390.5%
Cap/Sales(3y)0.01%
Cap/Sales(5y)5.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1229.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y180.38%
EPS Next 2Y105.4%
EPS Next 3Y69.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y49.76%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year35.88%
Revenue Next 2Y26.52%
Revenue Next 3Y24.09%
Revenue Next 5YN/A
EBIT growth 1Y-134.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.66%
EBIT Next 3Y70.39%
EBIT Next 5YN/A
FCF growth 1Y48.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y195.51%
OCF growth 3Y-47.24%
OCF growth 5YN/A

BULLISH / BLSH Fundamental Analysis FAQ

What is the fundamental rating for BLSH stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLSH.


What is the valuation status for BLSH stock?

ChartMill assigns a valuation rating of 2 / 10 to BULLISH (BLSH). This can be considered as Overvalued.


What is the profitability of BLSH stock?

BULLISH (BLSH) has a profitability rating of 1 / 10.


How financially healthy is BULLISH?

The financial health rating of BULLISH (BLSH) is 6 / 10.


What is the expected EPS growth for BULLISH (BLSH) stock?

The Earnings per Share (EPS) of BULLISH (BLSH) is expected to grow by 180.38% in the next year.